ArticleCancer science2016
Combination of panobinostat with ponatinib synergistically overcomes imatinib-resistant CML cells.
Yasufumi Matsuda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it